物理性状及指标：
外观：……………………白色至类白色结晶性粉末
熔点：……………………139-143 °C
溶解性：…………………本品溶于DMSO(60mg/ml)和丙酮，微溶于无水乙醇，几乎不溶于水。
含量：……………………≥99.0%
IC50：……………………20S 蛋白酶体：IC50 = 0.16 nM (小鼠)；A2780：IC50 = 1.7 nM (人)；
……………………………U266：IC50 = 2.45 nM (人)；RPMI18226：IC50 = 3.5 nM (人)；
……………………………HL-60: IC50 = 3.5 nM (human)
外观：……………………白色至类白色结晶性粉末
熔点：……………………139-143 °C
溶解性：…………………本品溶于DMSO(60mg/ml)和丙酮，微溶于无水乙醇，几乎不溶于水。
含量：……………………≥99.0%
IC50：……………………20S 蛋白酶体：IC50 = 0.16 nM (小鼠)；A2780：IC50 = 1.7 nM (人)；
……………………………U266：IC50 = 2.45 nM (人)；RPMI18226：IC50 = 3.5 nM (人)；
……………………………HL-60: IC50 = 3.5 nM (human)
搜索质检报告(COA)
搜索MSDS
硼替佐米
Bortezomib;Bortezomib (PS-341);((R)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid;bortezomib（Velcade®, Bortecad®, PS-341,MG-341）;Bortizomib; Bortezmib;Bortezomib Base;MG-341 PS-341;PS341;Radiciol;[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;Velcade;DPBA;MLM341;BortezMib;BortezoMib Base;MG-341 PS-341;BortezoMib-D8;BortezoMib R;BORTEZOMIB;Bortezomib for research;Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;VELCADE(BORTEZOMIB);VELCADE;dpba;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;PS-341;MG-341
